Table 3.

Physical performance in the follow-up assessment stratified by sex after adjustment by the follow-up interval.

	Control	SR	SRPF	Dunn’s adjusted value of p	Dunn’s q value
Handgrip (kgf)
Men	32.43 [27.22; 43.47]	34.66 [24.69; 37.98]	27.83 [24.57; 31.05]	n.s.	n.s.
Women	16.54 [8.50; 22.85]	10.09 [4.89; 18.37]	18.13 [15.77; 20.35]†	0.0082	0.0019
Up-and-go test (sec)
Men	10.62 [9.53; 12.24]	12.40 [11.07; 14.02]*	13.31 [12.30; 15.97]*	0.4205; 0.0133	0.0591; 0.0027
Women	12.96 [10.69; 14.30]	13.00 [11.24; 15.89]	13.04 [11.95; 16.29]	n.s.	n.s.
Borg dyspnoea scale, pre-test
Men	0.06 [-0.03; 0.30]	0.10 [-0.01; 0.96]	1.98 [0.64; 2.92]*,†	0.0062; 0.4592	0.0018; 0.0633
Women	0.28 [0.08; 1.95]	1.22 [0.07; 3.02]	1.21 [0.14; 3.03]	n.s.	n.s.
Borg dyspnoea scale, post-test difference (bpm)
Men	1.99 [0.47; 2.97]	3.01 [1.00; 3.31]	1.97 [1.08; 2.10]	n.s.	n.s.
Women	1.56 [0.48; 2.17]	1.95 [0.49; 3.00]	1.56 [0.98; 2.33]	n.s.	n.s.
Peripheral oxygen saturation, basal (%)
Men	97.28 [95.61; 98.16]	96.41 [94.66; 97.44]	96.80 [95.66; 97.82]	n.s.	n.s.
Women	97.06 [94.93; 97.84]	97.32 [96.31; 98.08]	96.59 [94.99; 97.67]	n.s.	n.s.
Peripheral oxygen saturation, post-test difference (%)
Men	0.42 [-0.11; 2.03]	0.01 [-1.01; 1.99]	0.07 [-0.89; 1.04]	n.s.	n.s.
Women	0.72 [0.01; 1.22]	-0.00 [-0.92; 0.83]	-0.05 [-0.99; 1.24]	n.s.	n.s.
Test repetitions (n)
Men	21.39 [18.51; 25.77]	19.03 [14.15; 24.44]	15.63 [12.16; 18.47]*,†	0.0018; 0.4568	0.0018; 0.0632
Women	18.91 [13.87; 23.33]	14.45 [12.01; 18.77]	13.60 [10.33; 16.27]	n.s.	n.s.

Comparisons were performed using the Kruskal-Wallis test followed by Dunn’s post-hoc test after adjustment by days to follow-up assessment. Statistical significance was considered when q < 0.063 in the Dunn’s post-hoc test. n.s. non-significant in Kruskall-Wallis test, post-hoc test not performed. * vs. Control; † vs. SR; SR, Self-Reported Symptoms; SRPF, Self-Reported Symptoms and decreased Pulmonary Function group.